News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
EY German Biotechonoly Report 2026: Funding down slightly – early-stage funding a cause for concern10.06.2026EY German Biotechonoly Report 2026: Funding down slightly – early-stage funding a cause for concernThe German biotechnology sector raised a total of EUR 1.8 billion in capital in 2025. This represents a five percent decline compared to the previous year. At the same time, the situation for… -
LMU opens new building for diagnostics and translational research10.06.2026LMU opens new building for diagnostics and translational researchTranslating excellent research findings from microbiology and virology into clinical diagnostics is an important step toward faster, more effective treatment and prevention of disease spread.… -
BIO-Europe 2025: Early bird rate expires on 1 July - Get the 12% Bio<sup>M</sup> discount now!10.06.2026BIO-Europe 2025: Early bird rate expires on 1 July - Get the 12% BioM discount now!BIO-Europe will take place from 9-11 November 2026 in Cologne (Germany). As the leading partnering conference in Europe, BIO-Europe brings together almost 8,000 visitors from over 60… -
SPRIND “Orbital Bioworks” Challenge08.06.2026SPRIND “Orbital Bioworks” ChallengeSPRIND – Federal Agency for Breakthrough Innovation has launched the new “Orbital Bioworks” challenge to support commercially viable biotechnology applications in microgravity. The program is… -
NUCLIDIUM expands its Series B extension to EUR 115 million27.05.2026NUCLIDIUM expands its Series B extension to EUR 115 millionThe radiopharmaceutical company NUCLIDIUM AG has raised an additional EUR 28.4 million in its Series B financing round. The company plans to use the capital to advance the clinical… -
Two new centers for Infectious Disease research in Bavaria19.05.2026Two new centers for Infectious Disease research in BavariaWith the ceremonial inauguration of the Center for Infection Prevention (ZIP) in Freising-Weihenstephan and the opening of the Bavarian Center for Preventive Infection Medicine (BZI) in… -
Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapy12.05.2026Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapyMedTech startup Sedivention has closed a €2.9 million seed financing round. The round was led by bmp Ventures with the IBG funds. Additional investors include the strategic investment arm of… -
NanoStruct secures €2.6 million in seed funding for fast sensor chip-based food safety11.05.2026NanoStruct secures €2.6 million in seed funding for fast sensor chip-based food safetyThe Würzburg-based deep-tech start-up NanoStruct has closed a €2.6 million seed financing round. The lead investors are HTGF, Bayern Kapital, and the Auxxo Female Catalyst Fund. NanoStruct’s… -
Apply now – Medical Valley Award 202605.05.2026Apply now – Medical Valley Award 2026The Medical Valley Award goes into its sixth round. Scientific projects in the medical field with spin-off potential can actively apply for EUR 500,000 in funding over a two-year… -
mbiomics secures EUR 30 million for the further development of microbiome-based therapeutics30.04.2026mbiomics secures EUR 30 million for the further development of microbiome-based therapeuticsThe Munich-based techbio company mbiomics has successfully expanded its Series A financing round to a total of EUR 30 million. With this capital, the company aims to advance the clinical…